What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Message Boards Settings Micromet, Inc. (MITI) - Quote Info
Re: Micromet Buys Out MedImmune's Remaining Rights to Blinatumomab      7-Nov-09 12:23 am    
thanks....I guess that makes sense.
I know incyte is doing the same thing....focusing on a small indication to get it drug approved faster to validate its platform.
Rating :
 (No ratings)
Rate it:
awful/not related to \pooraveragegoodexcellent

pyramidhunt

31/Male


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
(COMTEX) B: Micromet Buys Out MedImmune's Remaining...
ch17trader (2 Ratings) 5-Nov-09 06:35 am  
 
I love this news. LOVE IT!!
tagetlocman Rate it 5-Nov-09 09:06 am  
 
Great news, this is what we've been waiting f...
savyy_inves... Rate it 5-Nov-09 09:18 am  
 
Micromet will pay MedImmune a $6.5 milli...
jq1234_2000 Rate it 6-Nov-09 10:21 pm  
 
I still dont own miti. Why would m...
pyramidhunt Rate it 6-Nov-09 10:41 pm  
 
It had 85%+ cure rate in ALL -...
jq1234_2000 (1 Rating) 6-Nov-09 11:06 pm  
 
Re: Micromet Buys Out MedImmune's Remaining...
pyramidhunt Not rated 7-Nov-09 12:23 am  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Micromet, Inc. (MITI)

Chart for Micromet, Inc. (MITI)
On Nov 25: 6.92 Down 0.03 (0.43%)
Symbol Lookup